NIH Guide: Weekly Index for May 13, 2022

Funding Opportunities

• Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research
  (PA-22-175)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  (PAR-22-105)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): January 7, 2025
• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
  (PAR-22-106)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  John E. Fogarty International Center
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
  (PAR-22-109)
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): January 7, 2025
• Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed)
  (PAR-22-121)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
  (PAR-22-160)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  (PAR-22-167)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
  (PAR-22-182)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
  (PAR-22-183)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
  (PAR-22-184)
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-034)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 12, 2022
• Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-037)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 14, 2022
• Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
  (RFA-CA-22-027)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed)
  (RFA-DA-23-027)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 10, 2022
• Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
  (RFA-HG-22-002)
  National Human Genome Research Institute
  Application Receipt Date(s): July 27, 2022
• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
  (RFA-NS-22-071)
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  Application Receipt Date(s): June 17, 2022
• NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
  (RFA-RM-22-020)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 01, 2022